[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Radiofrequency Ablation Devices Market Size, Share & Trends Analysis Report By Product (Disposable, Capital, Reusable Equipment), By Application, By Region, And Segment Forecasts, 2019 - 2026

February 2019 | 100 pages | ID: R9E2566DEE9EN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 48 Business Hours

The global radiofrequency ablation devices market size is anticipated to reach USD 6.7 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to register a CAGR of 11.6% during the forecast period. Increasing preference for minimally invasive surgeries, growing geriatric population, and rise in healthcare spending for better disease treatment are expected to propel the growth.

According to the American Society of Plastic Surgeons, by the end of 2015, 15.9 million minimally invasive cosmetic surgeries were performed in U.S. According to the Centers for Disease Control and Prevention (CDC), more than six million laparoscopic procedures are performed across the U.S. and EU countries every year.

Radiofrequency ablation is now used early in the management of patients suffering from atrial tachycardia or atrial fibrillation or other kinds of coronary disease. This factor is anticipated to boost the market growth. According to the American College of Cardiology Foundation, coronary heart disease is the leading cause of deaths (43.8%) in U.S., followed by stroke (16.8%), heart failure (9.0%), high BP (9.4%), and other CVDs (17.9%). By 2035, the total cost of CVD is expected to reach USD 1.1 trillion and is projected to affect 45.1% (130 million) adults in U.S.

Radiofrequency ablation can also be used to reduce neck pain, low-back pain, arthritis, and pelvic and peripheral nerve pain. According to WebMD LLC., RFA has been proven to be effective in more than 70% of the patients experiencing pain. Pain relief from RFA can last from six to 12 months or even a year.

Further key findings from the report suggest:
  • Disposable equipment held the largest market share in 2018 due to reduced morbidity and mortality and the ability of the equipment to provide treatment in an outpatient setting. For example, Radiopaque RF cannula (Halyard Worldwide, Inc) provides improved visualization under fluoroscopy for accurate positioning, resulting in a targeted treatment
  • Cardiology and cardiac rhythm management is anticipated to be the fastest-growing segment during the forecast period due to disease prevalence, growing awareness, and adoption of minimally invasive operations. In 2012 RFA-Academia launched an initiative to increase awareness in Europe and to teach endoscopists safe and justified application of RFA to reduce the disease burden
  • North America is anticipated to continue leading the radiofrequency ablation devices market during the forecast period due to high healthcare expenditure, incidence of cardiac disease and cancer, and the number of patients suffering from pain
  • Asia Pacific is expected to witness significant growth over the next decade due to increasing demand for minimally invasive procedures to treat cancer and growing awareness regarding the benefits of ablation method over the conventional surgical procedures
  • Some of the key players are Boston Scientific Corporation; Medtronic; Stryker; Cosman Medical, Inc.; St. Jude Medical; Smith & Nephew; Johnson & Johnson (J&J) Services, LLC; and AngioDynamics.
CHAPTER 1 METHODOLOGY AND SCOPE

1.1 Market Segmentation & Scope
  1.1.1 Product
  1.1.2 Application
  1.1.3 Regional Scope
  1.1.4 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
  1.3.1 Data for primary interviews in North America
  1.3.2 Data for Primary Interviews in Europe
  1.3.3 Data for Primary Interviews in Europe
  1.3.4 Data for Primary Interviews in Latin America
  1.3.5 Data for Primary Interviews in MEA
1.4 Information or Data Analysis
  1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
  1.6.1 Commodity Flow Analysis (Model 1)
    1.6.1.1 Approach 1: Commodity Flow Approach
  1.6.2 Volume Price Analysis (Model 2)
    1.6.2.1 Approach 2: Volume Price Analysis
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
  1.10.1 Objective - 1:
  1.10.2 Objective - 2:

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Market Outlook
2.2 Segment Outlook
  2.2.1 Product
  2.2.2 Application
  2.2.3 Region
2.3 Competitive Insights

CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE

3.1 Market Lineage Outlook
  3.1.1 Parent Market Outlook
  3.1.2 Related/Ancillary Market Outlook
3.2 Market Segmentation
3.3 Penetration & Growth Prospect Mapping
3.4 Clinical Trials
3.5 User Perspective Analysis
  3.5.1 Consumer Behavior Analysis
  3.5.2 Market Influencer Analysis
3.6 List of Key End-users, by Region / by Product / by Country
3.7 Regulatory Framework & Reimbursement Scenario
  3.7.1.North America:
  3.7.2 Europe
  3.7.3 Asia Pacific
  3.7.4 Latin America
  3.7.5 Middle East
3.8 Market Dynamics
  3.8.1 Market Driver Analysis
    3.8.1.1 Increasing preference to minimally invasive procedures
    3.8.1.2 Increasing prevalence of cardiovascular diseases (CVD)
  3.8.2 Market Restraint Analysis
    3.8.2.1 Low awareness and availability of alternate treatment method
    3.8.2.2 High treatment cost
3.9 Business Environment Analysis Tools
  3.9.1 Porter’s Five Forces Analysis
    3.9.1.1 Bargaining power of buyers: Moderate
    3.9.1.2 Bargaining power of suppliers: Moderate
    3.9.1.3 Competitive rivalry: High
    3.9.1.4 Threat of new entrants: Moderate
    3.9.1.5 Threat of substitutes: High
  3.9.2 Pestel Analysis
    3.9.2.1 Political & Legal Landscape
    3.9.2.2 Economic Landscape
    3.9.2.3 Social Landscape
    3.9.2.4 Technological Landscape
    3.9.2.5 Environmental Landscape
  3.9.3 Major Deals & Strategic Alliances Analysis
    3.9.3.1 Joint Ventures
    3.9.3.2 Mergers & Acquisitions
    3.9.3.3 Technology Collaborations

CHAPTER 4 RADIOFREQUENCY ABLATION DEVICES MARKET: PRODUCT ANALYSIS

4.1 Radiofrequency Ablation Devices Product Market Share Analysis, 2018 & 2026
4.2 Radiofrequency Ablation Devices Product Market: Segment Dashboard:
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
  4.3.1 Capital Equipment
    4.3.1.1 Capital Equipment Market, 2015 - 2026 (USD Million)
  4.3.2 Disposable Equipment
    4.3.2.1 Disposable Equipment Market, 2015 - 2026 (USD Million)
  4.3.3 Reusable Equipment
    4.3.3.1 Reusable Equipment Market, 2015 - 2026 (USD Million)

CHAPTER 5 RADIOFREQUENCY ABLATION DEVICES MARKET: APPLICATION ANALYSIS

5.1 Radiofrequency Ablation Devices Application Market Share Analysis, 2018 & 2026
5.2 Radiofrequency Ablation Devices Application Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application
  5.3.1 Surgical Oncology
    5.3.1.1 Surgical Oncology Market, 2015 - 2026 (USD Million)
  5.3.2 Cardiology & Cardiac Rhythm ManagemenT
    5.3.2.1 Cardiology & Cardiac Rhythm Management Market, 2015 - 2026 (USD Million)
  5.3.3 Cosmetology
    5.3.3.1 Cosmetology Market, 2015 - 2026 (USD Million)
  5.3.4 Gynecology
    5.3.4.1 Gynecology Market, 2015 - 2026 (USD Million)
  5.3.5 Pain Management
    5.3.5.1 Pain Management Market, 2015 - 2026 (USD Million)

CHAPTER 6 RADIOFREQUENCY ABLATION DEVICES MARKET: REGIONAL ANALYSIS

6.1 Radiofrequency Ablation Devices Regional Market Share Analysis, 2018 & 2026
6.2 Radiofrequency Ablation Devices Regional Market: Segment Dashboard
6.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
6.4 List of Players at Regional Level
  6.4.1 North America
  6.4.2 Europe
  6.4.3 Asia Pacific
  6.4.4 Latin America
  6.4.5 MEA
6.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
  6.5.1 North America
  6.5.2 Europe
  6.5.3 Asia Pacific
  6.5.4 Latin America
6.6 Market Size, & Forecasts, and Trend Analysis, 2015 to 2026
6.7 North America
  6.7.1.North America Radiofrequency Ablation Devices Market, 2015 - 2026 (Usd Million)
  6.7.2 U.S.
    6.7.2.1 Regulatory & Reimbursement Scenario
    6.7.2.2 U.S. Radiofrequency Ablation Devices Market, 2015 - 2026 (USD Million)
  6.7.3 Canada
    6.7.3.1 Regulatory & Reimbursement Scenario
    6.7.3.2 Canada Radiofrequency Ablation Devices Market, 2015 - 2026 (USD Million)
6.8 Europe
  6.8.1.Europe Radiofrequency Ablation Devices Market, 2015 - 2026 (USD Million)
  6.8.2 Germany
    6.8.2.1 Germany Radiofrequency Ablation Devices Market, 2015 - 2026 (USD Million)
  6.8.3 U.K.
    6.8.3.1 U.K. Radiofrequency Ablation Devices Market, 2015 - 2026 (USD Million)
  6.8.4 France
    6.8.4.1 France Radiofrequency Ablation Devices Market, 2015 - 2026 (USD Million)
  6.8.5 Italy
    6.8.5.1 Italy Radiofrequency Ablation Devices Market, 2015 - 2026 (USD Million)
  6.8.6 Spain
    6.8.6.1 Spain Radiofrequency Ablation Devices Market, 2015 - 2026 (USD Million)
6.9 Asia Pacific
  6.9.1 Asia Pacific Radiofrequency Ablation Devices Market, 2015 - 2026 (USD Million)
  6.9.2 Japan
    6.9.2.1 Japan Radiofrequency Ablation Devices Market, 2015 - 2026 (USD Million)
  6.9.3 China
    6.9.3.1 China (Mainland) Radiofrequency Ablation Devices Market, 2015 - 2026 (USD Million)
  6.9.4 India
    6.9.4.1 India Radiofrequency Ablation Devices Market, 2015 - 2026 (USD Million)
6.10 Latin America
  6.10.1 Latin America Radiofrequency Ablation Devices Market, 2015 - 2026 (USD Million)
  6.10.2 Brazil
    6.10.2.1 Brazil Radiofrequency Ablation Devices Market, 2015 - 2026 (USD Million)
  6.10.3 Mexico
    6.10.3.1 Mexico Radiofrequency Ablation Devices Market, 2015 - 2026 (USD Million)
6.11 Middle East and Africa
  6.11.1.MEA Radiofrequency Ablation Devices Market, 2015 - 2026 (USD Million)
  6.11.2 South Africa
    6.11.2.1 South Africa Radiofrequency Ablation Devices Market, 2015 - 2026 (USD Million)

CHAPTER 7 COMPETITIVE ANALYSIS

7.1 Recent developments & impact analysis, by key market participants
7.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
7.3 Vendor Landscape
  7.3.1 LIst Of Key Distributors And Channel Partners
  7.3.2 Key Customers
  7.3.3 Strategy Mapping
7.4 Public Companies
  7.4.1 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength)
7.5 Private Companies
  7.5.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
  7.5.2 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
7.6 Company Profiles
  7.6.1 BOSTON SCIENTIFIC CORPORATION
    7.6.1.1 Company Overview
    7.6.1.2 Financial Performance
    7.6.1.3 Product Benchmarking
    7.6.1.4 Strategic Initiatives
    7.6.1.5 SWOT Analysis
  7.6.2 MEDTRONIC
    7.6.2.1 Company Overview
    7.6.2.2 Financial Performance
    7.6.2.3 Product Benchmarking
    7.6.2.4 Strategic Initiatives
    7.6.2.5 SWOT Analysis
  7.6.3 STRYKER
    7.6.3.1 Company Overview
    7.6.3.2 Financial Performance
    7.6.3.3 Product Benchmarking
    7.6.3.4 Strategic Initiatives
    7.6.3.5 SWOT Analysis
  7.6.4 COSMAN MEDICAL, INC.
    7.6.4.1 Company Overview
    7.6.4.2 Product Benchmarking
    7.6.4.3 Strategic Initiatives
  7.6.5 ST. JUDE MEDICAL
    7.6.5.1 Company Overview
    7.6.5.2 Financial Performance
    7.6.5.3 Product Benchmarking
    7.6.5.4 Strategic Initiatives
    7.6.5.5 SWOT Analysis
  7.6.6 SMITH & NEPHEW
    7.6.6.1 Company Overview
    7.6.6.2 Financial Performance
    7.6.6.3 Product Benchmarking
    7.6.6.4 Strategic Initiatives
    7.6.6.5 SWOT Analysis
  7.6.7 JOHNSON & JOHNSON (J&J) SERVICES, LLC
    7.6.7.1 Company Overview
    7.6.7.2 Financial Performance
    7.6.7.3 Product Benchmarking
    7.6.7.4 Strategic Initiatives
    7.6.7.5 SWOT Analysis
  7.6.8 ANGIODYNAMICS
    7.6.8.1 Company Overview
    7.6.8.2 Financial Performance
    7.6.8.3 Product Benchmarking
    7.6.8.4 Strategic Initiatives
    7.6.8.5 SWOT Analysis

CHAPTER 8 RECOMMENDATIONS


LIST OF TABLES

TABLE 1 Primary interview details: North America
TABLE 2 Primary interview details: Europe
TABLE 3 Primary interview details: APAC
TABLE 4 Primary interview details: Latin America
TABLE 5 Primary interview details: MEA
TABLE 6 List of secondary sources
TABLE 7 List of Abbreviation
TABLE 8 List of players in North America
TABLE 9 List of players in Europe
TABLE 10 List of players in Asia Pacific
TABLE 11 List of players in Latin America
TABLE 12 List of players in MEA
TABLE 13 North America Radiofrequency Ablation Devices Market, by Country, 2015 - 2026 (USD Million)
TABLE 14 North America Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 15 North America Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
TABLE 16 U.S. Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 17 U.S. Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
TABLE 18 Canada Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 19 Canada Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
TABLE 20 Europe Radiofrequency Ablation Devices Market, by Country, 2015 - 2026 (USD Million)
TABLE 21 Europe Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 22 Europe Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
TABLE 23 Germany Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 24 Germany Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
TABLE 25 U.K. Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 26 U.K. Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
TABLE 27 France Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 28 France Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
TABLE 29 Italy Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 30 Italy Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
TABLE 31 Spain Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 32 Spain Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
TABLE 33 Asia Pacific Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 34 Asia Pacific Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
TABLE 35 Japan Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 36 Japan Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
TABLE 37 China Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 38 China Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
TABLE 39 India Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 40 India Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
TABLE 41 Number of AF procedures carried out in each country of Latin America, 2012
TABLE 42 Latin America Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 43 Latin America Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
TABLE 44 Brazil Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 45 Brazil Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
TABLE 46 Mexico Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 47 Mexico Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
TABLE 48 MEA Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 49 MEA Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
TABLE 50 South Africa Radiofrequency Ablation Devices Market, by Product, 2015 - 2026 (USD Million)
TABLE 51 South Africa Radiofrequency Ablation Devices Market, by Application, 2015 - 2026 (USD Million)
LIST OF FIGURES

Fig.1 Market research process
Fig.2 Information procurement
Fig.3 Primary research pattern
Fig.4 Primary interviews in North America
Fig.5 Primary interviews in Europe
Fig.6 Primary interviews in APAC
Fig.7 Primary interviews in Latin America
Fig.8 Primary interviews in MEA
Fig.9 Market research approaches
Fig.10 Value-chain-based sizing & forecasting
Fig.11 QFD modeling for market share assessment
Fig.12 Market formulation & validation
Fig.13 Market outlook
Fig.14 Radiofrequency ablation devices market segmentation
Fig.15 Penetration & growth prospect mapping
Fig.16 Market trends & outlook
Fig.17 Market driver relevance analysis (Current & future impact)
Fig.18 Market restraint relevance analysis (Current & future impact)
Fig.19 Porter’s five forces analysis
Fig.20 PESTLE analysis
Fig.21 Radiofrequency ablation devices product market share analysis, 2018 & 2026
Fig.22 Radiofrequency ablation devices product market: Segment dashboard
Fig.23 Capital equipment market, 2015 - 2026 (USD Million)
Fig.24 Disposable equipment market, 2015 - 2026 (USD Million)
Fig.25 Reusable equipment market, 2015 - 2026 (USD Million)
Fig.26 Radiofrequency ablation devices application market share analysis, 2018 & 2026
Fig.27 Radiofrequency ablation devices application market: Segment dashboard
Fig.28 Surgical oncology market, 2015 - 2026 (USD Million)
Fig.29 Cardiology & cardiac rhythm management market, 2015 - 2026 (USD Million)
Fig.30 Cosmetology market, 2015 - 2026 (USD Million)
Fig.31 Gynecology market, 2015 - 2026 (USD Million)
Fig.32 Pain management market, 2015 - 2026 (USD Million)
Fig.33 Radiofrequency Ablation Devices regional market share analysis, 2018 & 2026
Fig.34 Radiofrequency ablation devices regional market: Segment dashboard
Fig.35 Regional market place: Key takeaways
Fig.36 North America Radiofrequency Ablation Devices market, 2015 - 2026 (USD Million)
Fig.37 U.S. radiofrequency ablation devices market, 2015 - 2026 (USD Million)
Fig.38 Canada radiofrequency ablation devices market, 2015 - 2026 (USD Million)
Fig.39 Europe radiofrequency ablation devices market, 2015 - 2026 (USD Million)
Fig.40 Germany. radiofrequency ablation devices market, 2015 - 2026 (USD Million)
Fig.41 U.K. radiofrequency ablation devices market, 2015 - 2026 (USD Million)
Fig.42 France radiofrequency ablation devices market, 2015 - 2026 (USD Million)
Fig.43 Italy radiofrequency ablation devices market, 2015 - 2026 (USD Million)
Fig.44 Spain radiofrequency ablation devices market, 2015 - 2026 (USD Million)
Fig.45 Asia Pacific radiofrequency ablation devices market, 2015 - 2026 (USD Million)
Fig.46 Japan radiofrequency ablation devices market, 2015 - 2026 (USD Million)
Fig.47 China radiofrequency ablation devices market, 2015 - 2026 (USD Million)
Fig.48 India radiofrequency ablation devices market, 2015 - 2026 (USD Million)
Fig.49 Latin America radiofrequency ablation devices market, 2015 - 2026 (USD Million)
Fig.50 Brazil radiofrequency ablation devices market, 2015 - 2026 (USD Million)
Fig.51 Mexico radiofrequency ablation devices market, 2015 - 2026 (USD Million)
Fig.52 MEA radiofrequency ablation devices market, 2015 - 2026 (USD Million)
Fig.53 South Africa radiofrequency ablation devices market, 2015 - 2026 (USD Million)
Fig.54 Strategy framework
Fig.55 Strategy framework
Fig.56 Strategy mapping
Fig.57 Company market position analysis (Revenue, geographic presence, product portfolio, strategic initiatives, employee strength)
Fig.58 Company market position analysis (Geographic presence, product portfolio, key alliance, industry experience)


More Publications